News

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and ...
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.